CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dirui Industrial Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dirui Industrial Co Ltd
No.3333 Yiju Road
High and New Technology Development Zone
Phone: +86 43181931002p:+86 43181931002 CHANGCHUN, JLN  130103  China Ticker: 300396300396
Business Summary
DIRUI INDUSTRIAL CO.,LTD is a China-based company principally engaged in the research, development, production and sale of medical testing equipment and supporting test paper and reagents. The Company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series and blood cell analysis series. The Company's products are used for routine physical examination and diagnosis of illness. The Company distributes its products in domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board QingSong 58 12/28/2020 12/28/2020
Chief Financial Officer, Deputy General Manager XingyanZhang 42 12/26/2023
General Manager, Director XueminWang 51 9/22/2021 9/22/2021
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,879 (As of 12/31/2022)
Outstanding Shares: 274,565,911 (As of 3/4/2024)
Shareholders: 8,794
Stock Exchange: SHE
Fax Number: +86 43181931002


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024